Equities

Polynovo Ltd

Polynovo Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)2.08
  • Today's Change-0.12 / -5.45%
  • Shares traded1.08m
  • 1 Year change+56.39%
  • Beta1.8575
Data delayed at least 20 minutes, as of May 17 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 16-May-24
Select bar for recommendation details.
Recommendations16-May-24
Buy1
Outperform4
Hold1
Underperform1
Sell0

Share price forecast in AUD

The 7 analysts offering 12 month price targets for Polynovo Ltd have a median target of 2.22, with a high estimate of 2.75 and a low estimate of 2.00. The median estimate represents a 6.73% increase from the last price of 2.08.
High32.2%2.75
Med6.7%2.22
Low-3.8%2.00

Earnings history & estimates in AUD

Polynovo Ltd reported annual 2023 losses of -0.013 per share on Aug 22, 2023.
Average growth rate-128.81%
More ▼

Revenue history & estimates in AUD

PolyNovo Limited had revenues for the full year 2023 of 65.24m. This was 55.74% above the prior year's results.
Average growth rate+46.28%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.